David Tweardy
Fortuna: 2 M $ al 31/05/2026
Fortuna: 2 M $ al 31/05/2026
David J.
Tweardy is associated with Tvardi Therapeutics, Inc. as the founder.
He held the position of President & Director at the company which was founded in 2017.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
6,92 % | 31/03/2026 | 649.046 ( 6,92 % ) | 2 M $ | 31/05/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
Tvardi Therapeutics, Inc.
Tvardi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel and oral molecule therapies for STAT3 to treat fibrosis-driven diseases | Fundador | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 1 |
|---|---|
Tvardi Therapeutics, Inc.
Tvardi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel and oral molecule therapies for STAT3 to treat fibrosis-driven diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.